Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zippelius

Showing results (281-290 of 308) with videos related to

Pageof 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung CancerMarcel P Trefny, Sacha I Rothschild, Franziska Uhlenbrock, et al.
Journal for Immunotherapy of Cancer|November 17, 2024
Inhibition of Cbl-b restores effector functions of human intratumoral NK cellsSofia Tundo, Marcel Trefny, Andrijana Rodić, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLCKarlijn Hummelink, Vincent van der Noort, Mirte Muller, et al.
The Journal of Clinical Investigation|August 22, 2018
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cellsMichal A Stanczak, Shoib S Siddiqui, Marcel P Trefny, et al.
Frontiers in Immunology|July 16, 2026
Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14)Yannik da Silva, Dapi Menglin Chiang, Laura Benecke, et al.
Immunity|December 16, 2018
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
Journal of Neurosurgery. Spine|June 7, 2024
Importance of the lumbar paraspinal muscles on the maintenance of global sagittal alignment after lumbar pedicle subtraction osteotomyThomas Caffard, Artine Arzani, Krizia Amoroso, et al.
Oncoimmunology|July 29, 2016
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinomaHans A Schlößer, Uta Drebber, Michael Kloth, et al.
Cancer Immunology Research|April 17, 2024
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating LymphocytesDavid König, Michael T Sandholzer, Sarp Uzun, et al.
Pageof 31

Showing results (281-290 of 308) with videos related to

Sort By:
Pageof 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung CancerMarcel P Trefny, Sacha I Rothschild, Franziska Uhlenbrock, et al.
Journal for Immunotherapy of Cancer|November 17, 2024
Inhibition of Cbl-b restores effector functions of human intratumoral NK cellsSofia Tundo, Marcel Trefny, Andrijana Rodić, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLCKarlijn Hummelink, Vincent van der Noort, Mirte Muller, et al.
The Journal of Clinical Investigation|August 22, 2018
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cellsMichal A Stanczak, Shoib S Siddiqui, Marcel P Trefny, et al.
Frontiers in Immunology|July 16, 2026
Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14)Yannik da Silva, Dapi Menglin Chiang, Laura Benecke, et al.
Immunity|December 16, 2018
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
Journal of Neurosurgery. Spine|June 7, 2024
Importance of the lumbar paraspinal muscles on the maintenance of global sagittal alignment after lumbar pedicle subtraction osteotomyThomas Caffard, Artine Arzani, Krizia Amoroso, et al.
Oncoimmunology|July 29, 2016
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinomaHans A Schlößer, Uta Drebber, Michael Kloth, et al.
Cancer Immunology Research|April 17, 2024
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating LymphocytesDavid König, Michael T Sandholzer, Sarp Uzun, et al.
Pageof 31